MabVax Therapeutics Holdings, Inc.
(Other OTC/NBB : MBVX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson -0.20%176.820.7%$1154.63m
LLYEli Lilly & Co. -0.88%368.691.1%$1059.24m
MRKMerck & Co., Inc. 0.36%110.490.7%$1006.28m
PFEPfizer Inc. 2.76%51.630.9%$961.54m
ABBVAbbVie, Inc. -0.18%165.111.9%$893.99m
BMYBristol-Myers Squibb Co. -0.41%79.601.1%$738.94m
AZNAstraZeneca Plc 0.47%69.181.0%$356.07m
HZNPHorizon Therapeutics Plc 1.19%97.455.4%$289.86m
GSKGSK Plc -0.31%36.770.3%$250.30m
IDXXIDEXX Laboratories, Inc. 1.36%425.803.9%$193.98m
NVSNovartis AG -0.38%91.380.2%$187.76m
ALNYAlnylam Pharmaceuticals, Inc. 2.67%237.518.0%$172.65m
CTLTCatalent, Inc. -4.15%45.261.9%$163.34m
NVONovo Nordisk A/S 1.85%127.560.1%$154.87m
SNYSanofi -1.64%47.160.2%$135.84m

Company Profile

MabVax Therapeutics Holdings, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing innovative vaccine and monoclonal antibody-based therapeutics for the diagnosis and treatment of cancer. The company was founded on July 8, 2014 and is headquartered in San Diego, CA.